GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eurobio Scientific (XPAR:ALERS) » Definitions » Change In Receivables

Eurobio Scientific (XPAR:ALERS) Change In Receivables : €12.8 Mil (TTM As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Eurobio Scientific Change In Receivables?

Eurobio Scientific's change in receivables for the quarter that ended in Dec. 2023 was €1.6 Mil. It means Eurobio Scientific's Accounts Receivable declined by €1.6 Mil from Jun. 2023 to Dec. 2023 .

Eurobio Scientific's change in receivables for the fiscal year that ended in Dec. 2023 was €12.8 Mil. It means Eurobio Scientific's Accounts Receivable declined by €12.8 Mil from Dec. 2022 to Dec. 2023 .

Eurobio Scientific's Accounts Receivable for the quarter that ended in Dec. 2023 was €26.9 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Eurobio Scientific's Days Sales Outstanding for the six months ended in Dec. 2023 was 68.97.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Eurobio Scientific's liquidation value for the six months ended in Dec. 2023 was €-21.2 Mil.


Eurobio Scientific Change In Receivables Historical Data

The historical data trend for Eurobio Scientific's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurobio Scientific Change In Receivables Chart

Eurobio Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.78 -31.93 1.90 21.45 12.78

Eurobio Scientific Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.43 6.58 14.88 11.22 1.55

Eurobio Scientific Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €12.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eurobio Scientific  (XPAR:ALERS) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Eurobio Scientific's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=26.937/71.274*91
=68.97

2. In Ben Graham's calculation of liquidation value, Eurobio Scientific's accounts receivable are only considered to be worth 75% of book value:

Eurobio Scientific's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=89.028-141.156+0.75 * 26.937+0.5 * 21.449
=-21.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eurobio Scientific Change In Receivables Related Terms

Thank you for viewing the detailed overview of Eurobio Scientific's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurobio Scientific (XPAR:ALERS) Business Description

Traded in Other Exchanges
Address
63-65 Boulevard Massena, Paris, FRA, 75013
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.

Eurobio Scientific (XPAR:ALERS) Headlines

No Headlines